Author | David Snyder, MD

Articles

Outlook for 2017: Myeloma, Lymphoma, and MPNs

December 23, 2016

This look ahead at hematologic malignancies in 2017 focuses on new agents being studied for the treatment of multiple myeloma, Hodgkin lymphoma, non-Hodgkin lymphoma, and myeloproliferative neoplasms.